European Pharma Innovation May Be Outpacing U.S., Health Affairs Article Concludes
This article was originally published in The Pink Sheet Daily
New Jersey professor analyzes proportion of R&D spending and proportion of NCEs in U.S., European nations and Japan, calling into question earlier Grabowski/Wang study reporting the U.S. had pulled ahead.
You may also be interested in...
Revised bill is expected shortly as Reps. Eshoo and Barton draw battle line against the Commerce Committee chairman.
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.